AILEEN TWOMEY: Open Payments
NPI 1619073434 · EMERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 19 payments from 10 companies in 2025. Trend: 2023 $111 · 2024 $657 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $133 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Incyte Corporation | 5 | $106 |
| Janssen Biotech, Inc. | 3 | $65 |
| Amgen Inc. | 3 | $50 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Sandoz Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, JAKAFI, TREMFYA, EVENITY, TZIELD, Korlym, JUBBONTI.
Industry payments across NJ — which companies pay providers there.
